---
schema_version: "secwatch.filing_event.v1"
accession: "0001412408-22-000049"
form_type: "8-K"
ticker: "PHR"
cik: "0001412408"
company_name: "Phreesia, Inc."
filed_at: "2022-09-07T23:59:59+00:00"
generated_at: "2026-06-23T14:01:09.719628+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Phreesia Q2 FY2023 revenue $67.9M (+33% YoY); raises FY revenue and EBITDA guidance

## Summary
- Revenue $67.9M, up 33% YoY; average healthcare clients 2,776 (+40% YoY).
- Adjusted EBITDA loss widened to $26.0M from $11.0M in prior year.
- FY2023 revenue guidance raised to $273M-$275M; Adj. EBITDA guidance improved to negative $106M-$109M.
- Cash $240.7M, down $73.1M from Jan; expects $165M-$170M by Jan 31, 2023.
- Average revenue per healthcare client $18,248, down 7% YoY as client growth outpaced payment volume.

## SEC filing metadata
- accession: 0001412408-22-000049
- form_type: 8-K
- ticker: PHR
- cik: 0001412408
- company_name: Phreesia, Inc.
- filed_at: 2022-09-07T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1412408/000141240822000049/0001412408-22-000049-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1412408/000141240822000049/phr-20220907.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001412408-22-000049
- JSON: https://secwatch.observer/filing/0001412408-22-000049.json
- Plain text: https://secwatch.observer/filing/0001412408-22-000049.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.